Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR5A1 | Q13285 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 2/20 | 0.59 |
| ▸ | THRA | P10827 | 1/20 | 0.57 |
| ▸ | LTA4H | P09960 | 3/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.54 |
| ▸ | CA3 | P07451 | 1/20 | 0.54 |
| ▸ | CA4 | P22748 | 1/20 | 0.54 |
| ▸ | CA6 | P23280 | 1/20 | 0.54 |
| ▸ | CA7 | P43166 | 1/20 | 0.54 |
| ▸ | CA9 | Q16790 | 1/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.54 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.54 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4945033 | 1.00 | NR5A1 (0.62) | NR5A1TSHRTHRALTA4HTP53 | |
| SCHEMBL10642885 | 1.00 | NR5A1 (0.62) | NR5A1TSHRTHRALTA4HTP53 | |
| SCHEMBL17018215 | 0.96 | NR5A1 (0.58) | NR5A1TSHRTHRALTA4HTP53 | |
| SCHEMBL30426140 | 0.96 | NR5A1 (0.58) | NR5A1TSHRTHRALTA4HTP53 | |
| SCHEMBL17162145 | 0.96 | NR5A1 (0.58) | NR5A1TSHRTHRALTA4HTP53 | |
| SCHEMBL19809314 | 0.93 | CA12 (0.59) | NR5A1THRALTA4HCA12CA1 | |
| SCHEMBL29779708 | 0.93 | CA12 (0.59) | NR5A1THRALTA4HCA12CA1 | |
| SCHEMBL11077065 | 0.92 | KDM4E (0.61) | NR5A1TSHRLTA4H | |
| SCHEMBL15762830 | 0.92 | NR5A1 (0.55) | NR5A1TSHRTHRALTA4HTP53 | |
| SCHEMBL5374714 | 0.92 | KDM4E (0.61) | NR5A1TSHRLTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120016147-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND POLYMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-01-19 | — | — | US | disclosed |
| US-8048982-B2 | Method for producing aromatic compound polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-11-01 | — | — | US | disclosed |
| EP-2241548-A1 | Vanadium di-nuclear complex | Sumitomo Chemical Company, Limited (JP) | 2010-10-20 | — | — | EP | disclosed |
| EP-2241547-A1 | Method for producing aromatic compound polymer | Sumitomo Chemical Company, Limited (JP) | 2010-10-20 | — | — | EP | disclosed |
| US-20090018309-A1 | Method for Producing Aromatic Compound Polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-01-15 | — | — | US | disclosed |
| EP-1767560-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND POLYMER | Sumitomo Chemical Company, Limited (JP) | 2007-03-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090018309-A1 | Method for Producing Aromatic Compound Polymer | PAH, MAOA, AHR | NR5A1 1330/4885TSHR 3657/4885THRA 2080/4885 |
| US-20120016147-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND POLYMER | PAH, MAOA, AHR | NR5A1 1291/4885TSHR 3727/4885THRA 2206/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.